
Licensed to fill prescriptions for patients in RI, MA, CT, NJ, NH, FL, ME and PA. New York patients are served on a limited basis while nonresident registration is pending.
Prepared to a prescriber's order for one patient. Not FDA-approved.
This is a compounded topical cream containing urea, prepared to a prescriber's order for one patient. Compounded preparations are not FDA-approved.
These listings cover every salt or ester form of each drug in the FDA National Drug Code Directory.
No FDA-approved (NDA or ANDA) product containing urea is listed. Products containing it are filed in the directory as unapproved drugs, over-the-counter monograph drugs and homeopathic products, in cream, lotion, liquid and gel forms.
This dose form is water-containing (aqueous). Under USP <795>, aqueous preparations carry shorter default beyond-use dates than nonaqueous ones, and a preservative in the base allows a longer date than no preservative. The date printed on the label is the one to follow.
Compounded drugs are not FDA-approved. This means that FDA does not review these drugs to evaluate their safety, effectiveness, or quality before they reach patients.
Urea is a keratolytic and moisturizing agent that compounding pharmacies prepare as topical creams, ointments, gels and nail preparations by prescription.
Urea is a small molecule found naturally in skin, where it helps hold water in the outer layer. At low strengths it acts as a humectant, drawing water into the stratum corneum. At higher strengths it is keratolytic: it breaks hydrogen bonds and loosens keratin so thickened, scaly skin and dystrophic nails soften and shed. Manufactured urea creams, lotions, gels and foams are sold over the counter and by prescription. The prescription 40 percent creams are marketed as unapproved drugs; their labels list hyperkeratotic conditions such as xerosis, ichthyosis, calluses, keratoses, eczema and psoriasis, and the label states that FDA has not evaluated the product. A prescriber might order compounded urea for a strength or vehicle not manufactured, a fragrance-free base, or a combination with another topical ingredient. Compounded preparations are not FDA-approved and require a prescription.
Urea is for external use only. Keep it away from the eyes, lips and mucous membranes, and do not apply it to open wounds, burns or swollen skin. The most common side effects are brief stinging, burning, itching or redness where it is applied, which usually settle when use stops. Stop and call your prescriber for severe redness, a rash, hives, trouble breathing, or if the treated area gets worse. Urea can increase how much of another topical drug, such as a corticosteroid or antifungal, passes into the skin, so tell your prescriber about every cream you use; oral medicines are unlikely to interact with it. The manufactured label says it is not known whether urea passes into breast milk and that pregnant patients should use it only if clearly needed; LactMed has no urea record. If side effects bother you, talk to your prescriber or pharmacist.
Urea is a natural moisturizing factor component. The manufactured label states the mechanism of topical urea is not established; it attributes the clinical effect to dissolution of the intercellular matrix of the horny layer. The clinical literature describes concentration-dependent activity: hydration and reduced transepidermal water loss at lower strengths, and proteolytic, keratolytic action with keratin denaturation and epidermal thinning at higher strengths. Urea is not absorbed to a meaningful systemic degree and no systemic toxicity has been reported with topical use. Manufactured products are marketed under the unapproved-drug category; labeled indications on the 40 percent prescription creams (Method Pharmaceuticals and others) include xerosis, ichthyosis, skin cracks and fissures, dermatitis, eczema, psoriasis, keratoses and calluses. Prescribers have ordered compounded urea for nonsurgical avulsion of dystrophic nails under occlusion, as a penetration enhancer alongside topical corticosteroids and antifungals, and in combination with salicylic acid or lactic acid for scaling disorders (Pan et al., Dermatology Online Journal 2013). Strength, vehicle and occlusion are per prescriber. Monitoring is clinical: local irritation, maceration after nail avulsion, and response of the treated area. Long-term carcinogenicity, mutagenicity and fertility studies have not been performed. Urea is not a controlled substance.
Wash your hands. Apply the amount on your label to clean, dry skin and rub it in gently. For a metered pump, each press delivers a set amount; your label states how many presses. For transdermal creams, apply to the area your label names and let it dry before dressing. Wash your hands afterward and avoid skin-to-skin contact with others at the application site until it has absorbed. Do not apply to broken skin unless told to.
Creams are aqueous. Under USP <795>, a preserved cream usually carries a beyond-use date of up to 35 days at room temperature or refrigerated, and an unpreserved one 14 days refrigerated. Follow the storage line on your label, keep from freezing, keep out of reach of children, and discard after the beyond-use date.
This formulation is compounded by Bayview Pharmacy on a prescriber's order for an individual patient. It is not an FDA-approved drug product, and the FDA has not evaluated it for safety, effectiveness, or manufacturing quality.
A valid prescription is required. Availability depends on Bayview's licensure in your state. This page is general information, not medical advice. Discuss your situation with a licensed healthcare provider.
Search by NCPDP 4106882, or by name and ZIP: Bayview Pharmacy, Warwick, RI 02886. Select it as the destination pharmacy and save it as a favorite. Click any value to copy it.
Compounded preparations have no NDC, so this formula will not appear in your EHR's drug search. Use your system's compound, non-formulary, or free-text prescription entry and name the preparation exactly as written in step 3. If your EHR forces you to pick a listed drug, pick the closest entry for the active ingredient and put the full formula in the prescription body (the Sig or directions field), not in Notes to Pharmacy.
Compounded preparations have no NDC and will not appear in your drug search. For EPCS to validate, select a drug entry your EHR recognizes as controlled, usually the bulk powder entry for the active ingredient (for example Ketamine (bulk) powder, not a branded product), then put the full formula from step 3 in the prescription body. A free-text entry that does not validate as controlled will be rejected by your EPCS module.
Quantity and directions are starting points for this dose form, not treatment recommendations. Dosing remains the prescriber's responsibility.
Transmit from your EHR. For this non-controlled preparation we also accept fax to (401) 284-4506 and phoned orders at (401) 284-4505. Order forms are on the formulation pages and in the prescriber portal.
Transmit with two-factor authentication through your EPCS-enabled EHR. No order form is offered for this preparation; e-prescribing guides for our controlled preparations are on the formulation pages.
Licensed to dispense in RI, MA, CT, NJ, NH, FL, ME, and PA; New York is served on a limited basis while nonresident registration is pending. Compounded preparations are not FDA-approved. A valid prescription is required. Full guide, including steps by EHR: How to e-prescribe to Bayview. Questions about this formula: call (401) 284-4505.
Apply topically to affected area(s)